356 related articles for article (PubMed ID: 31414640)
1. Value of cardiopulmonary exercise testing in the diagnosis of coronary artery disease.
Akıncı Özyürek B; Savaş Bozbaş Ş; Aydınalp A; Bozbaş H; Ulubay G
Tuberk Toraks; 2019 Jun; 67(2):102-107. PubMed ID: 31414640
[TBL] [Abstract][Full Text] [Related]
2. Quantification of coronary artery disease using different modalities of cardiopulmonary exercise testing.
Popovic D; Guazzi M; Jakovljevic DG; Lasica R; Banovic M; Ostojic M; Arena R
Int J Cardiol; 2019 Jun; 285():11-13. PubMed ID: 30879940
[TBL] [Abstract][Full Text] [Related]
3. Adoption of the cardiopulmonary exercise test in the exercise ability and cardiopulmonary function rehabilitation of coronary artery disease (CAD) patients.
Wang L; Mei F; Min M; He X; Luo L; Ma Y
BMC Cardiovasc Disord; 2024 Jun; 24(1):313. PubMed ID: 38902630
[TBL] [Abstract][Full Text] [Related]
4. Oxygen consumption and carbon-dioxide recovery kinetics in the prediction of coronary artery disease severity and outcome.
Popovic D; Martic D; Djordjevic T; Pesic V; Guazzi M; Myers J; Mohebi R; Arena R
Int J Cardiol; 2017 Dec; 248():39-45. PubMed ID: 28689985
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cardiopulmonary exercise testing variables in COPD patients with and without coronary artery disease.
Thirapatarapong W; Armstrong HF; Bartels MN
Heart Lung; 2014; 43(2):146-51. PubMed ID: 24594250
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary practice in the postoperative cardiopulmonary exercise testing for children with congenital heart disease].
Cai XM; Xu ZM; Xu YC; Chen L; Zhang H
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):471-479. PubMed ID: 35589596
[No Abstract] [Full Text] [Related]
7. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
Ganesananthan S; Rajkumar CA; Foley M; Thompson D; Nowbar AN; Seligman H; Petraco R; Sen S; Nijjer S; Thom SA; Wensel R; Davies J; Francis D; Shun-Shin M; Howard J; Al-Lamee R
Eur Heart J; 2022 Sep; 43(33):3132-3145. PubMed ID: 35639660
[TBL] [Abstract][Full Text] [Related]
8. [Cardiopulmonary exercise capacity in adult patients with atrial septal defect].
Suchoń E; Podolec P; Tomkiewicz-Pajak L; Kostkiewicz M; Mura A; Pasowicz M; Tracz W
Przegl Lek; 2002; 59(9):747-51. PubMed ID: 12632902
[TBL] [Abstract][Full Text] [Related]
9. Isocapnic buffering phase: a useful indicator of exercise endurance in patients with coronary artery disease.
Yen YS; Su DCJ; Yuan KS; Chen PW; Chow JC; Chou W
Phys Sportsmed; 2018 May; 46(2):228-232. PubMed ID: 29320309
[TBL] [Abstract][Full Text] [Related]
10. Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy.
Mapelli M; Romani S; Magrì D; Merlo M; Cittar M; Masè M; Muratori M; Gallo G; Sclafani M; Carriere C; Zaffalon D; Salvioni E; Mattavelli I; Vignati C; De Martino F; Rovai S; Autore C; Sinagra G; Agostoni P
Heart; 2022 Sep; 108(20):1629-1636. PubMed ID: 35273123
[TBL] [Abstract][Full Text] [Related]
11. Circulatory and Ventilatory Power: Characterization in Patients with Coronary Artery Disease.
Castello-Simões V; Minatel V; Karsten M; Simões RP; Perseguini NM; Milan JC; Arena R; Neves LM; Borghi-Silva A; Catai AM
Arq Bras Cardiol; 2015 Jun; 104(6):476-85. PubMed ID: 26131703
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prognostic values of cardiopulmonary and heart rate parameters in exercise testing in men with heart failure.
Czubaszewski Ł; Straburzyńska-Lupa A; Migaj J; Straburzyńska-Migaj E
Cardiol J; 2018; 25(6):701-708. PubMed ID: 28612902
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
Klaren RE; Sandroff BM; Fernhall B; Motl RW
Sports Med; 2016 Sep; 46(9):1365-79. PubMed ID: 26801918
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary Exercise Testing in Combined Pulmonary Fibrosis and Emphysema.
Westhoff M; Litterst P; Ewert R
Respiration; 2021; 100(5):395-403. PubMed ID: 33657565
[TBL] [Abstract][Full Text] [Related]
15. The relationship between homocysteine and cardiopulmonary exercise testing in patients with acute coronary syndrome after percutaneous coronary intervention.
Luo JT; Zeng CM; Zhao YM; Zeng ZY
BMC Cardiovasc Disord; 2023 Jan; 23(1):3. PubMed ID: 36609219
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary exercise testing versus pulmonary function test in the assessment of respiratory impairment in chronic obstructive pulmonary disease patients.
Salama S; Mohamed-Hussein AA; Magdy DM; Salama A
Adv Respir Med; 2022; 90(3):202-210. PubMed ID: 35731113
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
Vainshelboim B; Oliveira J; Fox BD; Kramer MR
Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of cardiopulmonary exercise parameters in patients with valvular heart disease.
Lehmann G; Kölling K
Chest; 1996 Sep; 110(3):685-92. PubMed ID: 8797412
[TBL] [Abstract][Full Text] [Related]
19. [Effect of different work rate increasing rate on the overall function evaluation of cardiopulmonary exercise testing II- sub-peak parameters].
Hao L; Sun XG; Song Y; Liu F; Tai WQ; Ge WG; Li H; Zhang Y; Chen R; Zou YX; Ma MX; Xia R; Huang Y; Xie YH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Mar; 37(2):120-124. PubMed ID: 34672148
[No Abstract] [Full Text] [Related]
20. Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial.
Wheeler MT; Olivotto I; Elliott PM; Saberi S; Owens AT; Maurer MS; Masri A; Sehnert AJ; Edelberg JM; Chen YM; Florea V; Malhotra R; Wang A; Oreziak A; Myers J
JAMA Cardiol; 2023 Mar; 8(3):240-247. PubMed ID: 36652223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
